Welcome to MSP's Digital RDD Table

*Diese Seite ist leider nur in Englisch verfügbar.*

MSP, a Division of TSI, welcomes you to our digital RDD table! We wish we could have met you in-person, and we hope you are staying safe and healthy. Please take a minute to peruse some of our RDD highlights below, and let us know (through the RDD messaging capability or by filling out the form at the bottom of this page) if you have any questions, comments, or would like to chat!

Below you will find information on our NEW NGI+ product launch, the IVIVc and automation equipment we offer, and information on our upcoming webinar. Thank you for visiting our website to learn more about how MSP can help you.

The NGI+

Coming soon

With enhanced chemical and biological resistance, the NGI+ enables a wider range of applications.

Additional Features:

• Extended equipment life
• Enhanced corrosion resistance
• Allows for more robust cleaning methods
• Backwards compatible^*† — upgrade your existing NGI or buy a completely new NGI

^* Ask for availability for your equipment
^† Drug and aerosol performance does not change

Want to be notified when the NGI+ becomes available? Sign up below!

Sign up

In-Vitro In-Vivo Correlation

MSP's IVIVc equipment simulates real life breathing patterns for inhaler testing.

• Replicates a variety of patient conditions
• Reduces risk and time in clinical trials
• Provides a competitive edge early in development

Automation Equipment

Controlling as many variables as possible is important for good analytical development and enables scaling consistent methods. MSP provides solutions from basic tasks and functionality to more semi-automated functions.

Our automation solutions:

• Reduce variability
• Produce more consistent data
• Minimize errors
• Streamline method development and transfer
• Improve labor utilization
• Increase throughput

Upcoming Webinar

Inhalation Drug Development Post COVID-19

MSP is hosting a 30 minute webinar, with Q&A after, dedicated to helping you improve lab efficiency and utilization on Wednesday, April 29th at 1 PM CDT.

The COVID-19 pandemic has had far-reaching implications. How do we adapt to our current environment and efficiently ramp our projects and method development back up - decreasing costs and improving lab/labor usage?

This webinar looks at:

• COVID-19 impact on industry and drug development
• Sources of variability
• Efficiency, productivity, and reproducibility
• To automate or not to automate?

Incorporating automation into your lab provides a wide range of benefits, including:

• Saving time
• Decreasing cost
• Increasing consistency
• Improving throughput

Help bring your lab back even stronger than before, post COVID-19

Date: April 29th, 2020
Time: 1:00 PM - 1:30 PM (CDT), with questions afterward

Register today

Contact Us

Ask us a question, give us feedback, or just start a conversation by filling out the form below. We look forward to talking with you!